MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2022 International Congress

    Intensive Multimodal Rehabilitation Intervention for Moderately Advanced Parkinson’s Disease

    P. Moondra, A. Di Rocco, L. Rubin, C. Claro, A. Persaud, M. Mccrossin, A. Hernandez, D. Barreto, K. Schlosser, E. Stack, P. Fischetti, J. Yu, D. Green, L. Ptarcinski, K. Greco, G. Fequiere, C. Francavilla, B. Rubin, M. Tursi, J. Colton (Manhasset, USA)

    Objective: To measure the impact of intensive multimodal neurorehabilitation in patients with moderately advanced with Parkinson’s disease (PD) Background: Dedicated neurorehabilitation is an essential part…
  • 2022 International Congress

    Delayed post-stroke parkinsonism: description of two cases and possible mechanism

    T. Friedeman- Korn, M. Bauer, M. Abu Snineh, C. Weill, D. Arkadir (Jerusalem, Israel)

    Objective: To present two patients who developed delayed parkinsonism years after experiencing midbrain strokes and to suggest a possible mechanism for this delayed phenomenon. Background:…
  • 2022 International Congress

    Diagnostic Utility of I123-FP-CIT Single Photon Emission Computed Tomography for Patients with Clinically Uncertain Parkinsonian Syndrome

    R. Falconer, T. Hunter, E. Szabo, C. Brand (Alexandria, USA)

    Objective: This study investigated the impact of I123-FP-CIT single photon emission computed tomography (SPECT) for the diagnosis of patients with clinically uncertain parkinsonian syndrome (CUPS)…
  • 2022 International Congress

    Serum Metabolomic Characterization of PLA2G6-associated Dystonia-Parkinsonism: a case-control biomarker study

    C. Chen, M. Lou, Y. Sun, W. Wang, J. Wang (Shanghai, China)

    Objective: PLA2G6 is the causative gene for autosomal recessive Dystonia-Parkinsonism (PARK14). This case-control biomarker study aimed to test serum metabolomics of patients diagnosed as PARK14.…
  • 2022 International Congress

    A Case of Neurodegeneration with Brain Iron Accumulation with novel Adaptor Protein-4 M1 subunit mutation

    A. Battineni, D. Vijayakumar (Greenville, USA)

    Objective: To present a patient with clinical and radiological features of neurodegeneration with brain iron accumulation (NBIA) due to a novel variant mutation in adaptor…
  • 2022 International Congress

    Multi-modal MRI features and their relationship with clinical scales in Parkinson disease and Atypical Parkinsonian Syndromes

    H. Martinez-Hernandez, D. Lopez-Mena, B. Candela-Solano, A. Medina-Islas, L. Alvarez, I. Acosta (Mexico City, Mexico)

    Objective: To compare MRI sings and volumetric measurements in Parkinson disease (PD), Progressive Supranuclear Palsy (PSP), and Multiple System Atrophy (MSA) and their relationship with…
  • MDS Virtual Congress 2021

    Racial and ethnic differences in patients with Parkinson’s Disease across Parkinson’s Disease Centers of Excellence

    D. Di Luca, S. Luo, T. Davis, A. Ramirez-Zamora, M. Rafferty, N. Dahodwala, C. Marras (Toronto, Canada)

    Objective: To investigate treatment, health-related quality of life, and other outcome differences in patients with Parkinson’s Disease (PD) across race and ethnicity. Background: The inclusion…
  • MDS Virtual Congress 2021

    Terminal Choking in Parkinson’s Disease

    F. Herbert, A. Ling, E. Richfield, B. Wright (Gloucester, United Kingdom)

    Objective: To establish whether choking is a frequent cause of death in Parkinson’s Disease (PD), if this is a feared consequence of PD in patients/caregivers…
  • MDS Virtual Congress 2021

    Long-Term Evaluation of Deep Brain Stimulation for Treatment of Parkinson’s Disease Using a Multiple-Source, Constant-Current Rechargeable System: 4-year Follow-Up of a Prospective, Double-Blind RCT

    J. Vitek, R. Jain, L. Chen, A. Tröster, L. Schrock, P. House, M. Giroux, A. Hebb, S. Farris, D. Whiting, T. Lechleiter, J. Ostrem, M. San Luciano, N. Galifianakis, L. Verhagen Metman, S. Sani, J. Karl, M. Siddiqui, S. Tatter, I. Ul Haq, A. Machado, M. Gostkowski, M. Tagliati, A. Mamelak, M. Okun, K. Foote, G. Moguel-Cobos, F. Ponce, R. Pahwa, J. Nazarro, C. Buetefisch, R. Gross, C. Luca, J. Jagid, G. Revuelta, I. Takacs, M. Pourfar, A. Mogilner, A. Duker, G. Mandybur, J. Rosenow, S. Cooper, M. Park, S. Khandhar, M. Sedrak, F. Phibbs, J. Pilitsis, R. Uitti, P. Starr (Minneapolis, USA)

    Objective: The long-term effectiveness of a Deep Brain Stimulation (DBS) device capable of Multiple Independent Current Control (MICC) is assessed in a prospective, sham-controlled, double-blind…
  • MDS Virtual Congress 2021

    Benign Progressive Supranuclear Palsy: mild pathology associated with parkinsonism

    B. Couto, I. Martinez-Balbuena, S. Lee, N. Visanji, A. Lang, G. Kovacs (Toronto, Canada)

    Objective: Objective: To describe the clinical presentation and neuropathology of cases where the degree of tau pathology is mild, and the neuronal loss is anatomically…
  • « Previous Page
  • 1
  • …
  • 81
  • 82
  • 83
  • 84
  • 85
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley